Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027066 (
myoclonus
)
4,275
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hereditary spinocerebellar ataxia (SCA) is a cluster of heterogeneous disorders. At now, 29 dominant loci have been assigned. Responsible genes and mutations are determined in at least 14 of them. In recessive and X-linked SCAs, 15 loci have been mapped, and mutation in each gene is determined by 6 disorders. Molecular mechanism of those SCAs are variable. Generally, deletion, insertion, or substitution in a gene modifies the primary structure of mRNA, subsequently resulting in disturbance of transcription or in translation of mutant proteins showing loss-of-function or dominant negative effect. Large expansion of tandem repeat in promotor region or intron suppress translation of the gene, thus causing similar effect. Expansion of (CAG)n in coding exon is translated into proteins containing elongated poly-Q. Since the poly-Q fragment is cytotoxic, this kind of mutation causes protein toxic gain-of-function. In addition, RNA toxic gain-of-function mechanism recently gains attention as a new molecular mechanism of
SCA8
and SCA10. Clinically, dominant SCA with dynamic mutation shows variable onset of age, severity, and variation of clinical phenotypes. Among this clinical complexity, vocal cord abductor paralysis in SCA1, familial parkinsonism in SCA2, vestibular dysfunction and axonal neuropathy in MJD, and axial
myoclonus
in SCA14, are reviewed for potential usefulness in clinical practice.
...
PMID:[Clinical feature and molecular genetics of hereditary spinocerebellar ataxia]. 1821 Aug 1
We report a family with 16q-ADCA(16q 22.1 linked autosomal dominant cerebellar ataxia) coexisting with
SCA8
repeat expansion. The brothers in this family presented with pyramidal signs, tremor,
myoclonus
and mental retardation in addition to cerebellar symptom in childhood. They showed both C-to-T substitution puratrophin-1 gene and an expanded allele of the
SCA8
gene in the brothers and their father. These siblings presented with atypical symptoms and early onset age as16q-ADCA. Although it remains controversial whether the expanded
SCA8
allele is associated with cerebellar symptoms, the coexistence of
SCA8
repeat expansion with SCA6 was reported previously. Pure or predominant cerebellar symptoms were found in patients with
SCA8
, SCA6 and 16q-ADCA. In addition, common findings in neuropathology of
SCA8
, SCA6 and 16q-ADCA have been reported. We suppose that coexistence of
SCA8
repeat expansion with 16q-ADCA may be involved in the pathogenesis and severe symptoms in this family.
...
PMID:Severe symptoms of 16q-ADCA coexisting with SCA8 repeat expansion. 1868 74